Filing Details

Accession Number:
0000899243-20-029078
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-22 19:41:02
Reporting Period:
2020-10-20
Accepted Time:
2020-10-22 19:41:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1719395 Eargo Inc. EAR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1606387 Peter Bisgaard C/O Eargo, Inc.
1600 Technology Drive, 6Th Floor
San Jose CA 95110
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-20 41,969 $0.00 41,969 No 4 C Direct
Common Stock Acquisiton 2020-10-20 2,664,502 $0.00 2,664,502 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-10-20 222,222 $18.00 2,886,724 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 C Indirect See footnote
No 4 P Indirect See footnotes
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2020-10-20 11,086 $0.00 12,402 $0.00
Common Stock Series C Preferred Stock Disposition 2020-10-20 1,330,361 $0.00 1,488,369 $0.00
Common Stock Series D Preferred Stock Disposition 2020-10-20 3,738 $0.00 4,660 $0.00
Common Stock Series D Preferred Stock Disposition 2020-10-20 261,701 $0.00 326,275 $0.00
Common Stock Series E Preferred Stock Disposition 2020-10-20 24,907 $0.00 24,907 $0.00
Common Stock Series E Preferred Stock Disposition 2020-10-20 849,858 $0.00 849,858 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Indirect
0 No 4 C Direct
0 No 4 C Indirect
0 No 4 C Direct
0 No 4 C Indirect
Footnotes
  1. The Series C Preferred Stock automatically converted into shares of Common Stock on a 1:1.118772093 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  2. The Series D Preferred Stock automatically converted into shares of Common Stock on a 1:1.246748888 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  3. The Series E Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
  4. These shares are held directly by Pivotal Alpha Limited ("Pivotal"). Investment and voting decisions by Pivotal are made jointly by the executive committee of Nan Fung Group Holdings Limited (the "NFGHL Executive Committee"), which indirectly owns Pivotal. Kam Chung Leung, Frank Kai Shui Seto, Vincent Sai Sing Cheung, Pui Kuen Cheung, Kin Ho Kwok, Vanessa Tih Lin Cheung, Meng Gao and Chun Wai Nelson Tang are each on the NFGHL Executive Committee. Mr. Bisgaard is a Managing Partner of Pivotal Bioventure Partners LLC, which is affiliated with Pivotal, and disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.
  5. Includes 2,664,502 shares held directly by Pivotal Alpha Limited ("Pivotal") and 222,222 shares held directly by Permwell Management Limited ("Permwell"). Investment and voting decisions by Pivotal are made jointly by the executive committee of Nan Fung Group Holdings Limited (the "NFGHL Executive Committee"), which indirectly owns Pivotal and Permwell. Investment decisions by Permwell are generally made by Nan Fung Trinity (HK) Limited, which is indirectly owned by Nan Fung Group Holdings Limited. Voting decisions by Permwell are made by the NFGHL Executive Committee.
  6. (Continued from footnote 5) Kam Chung Leung, Frank Kai Shui Seto, Vincent Sai Sing Cheung, Pui Kuen Cheung, Kin Ho Kwok, Vanessa Tih Lin Cheung, Meng Gao and Chun Wai Nelson Tang are each on the NFGHL Executive Committee. Mr. Bisgaard is a Managing Partner of Pivotal Bioventure Partners LLC, which is affiliated with Pivotal and Permwell, and disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.